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Abstract
Background: Earlier we have reported translational control of interferon regulatory factor 2 (IRF2) by internal initiation (Dhar
et al, Nucleic Acids Res, 2007). The results implied possible role of IRF2 in controlling the intricate balance of cellular gene
expression under stress conditions in general. Here we have investigated the secondary structure of the Internal Ribosome
Entry Site of IRF2 RNA and demonstrated the role of PTB protein in ribosome assembly to facilitate internal initiation.
Methodology/Principal Findings: We have probed the putative secondary structure of the IRF2 59UTR RNA using various
enzymatic and chemical modification agents to constrain the secondary structure predicted from RNA folding algorithm
Mfold. The IRES activity was found to be influenced by the interaction of trans-acting factor, polypyrimidine tract binding
protein (PTB). Deletion of 25 nts from the 39terminus of the 59untranslated region resulted in reduced binding with PTB
protein and also showed significant decrease in IRES activity compared to the wild type. We have also demonstrated
putative contact points of PTB on the IRF2–59UTR using primer extension inhibition assay. Majority of the PTB toe-prints
were found to be restricted to the 39end of the IRES. Additionally, Circular Dichroism (CD) spectra analysis suggested change
in the conformation of the RNA upon PTB binding. Further, binding studies using S10 extract from HeLa cells, partially
silenced for PTB gene expression, resulted in reduced binding by other trans-acting factors. Finally, we have demonstrated
that addition of recombinant PTB enhances ribosome assembly on IRF2 IRES suggesting possible role of PTB in mediating
internal initiation of translation of IRF2 RNA.
Conclusion/Significance: It appears that PTB binding to multiple sites within IRF2 59UTR leads to a conformational change
in the RNA that facilitate binding of other trans-acting factors to mediate internal initiation of translation.
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Introduction
Initiation of translation of the majority of the eukaryotic cellular
mRNAs is mediated by the cap-dependent mode of translation
which results from binding of ribosomes to the m
7G cap at the 59
end of the mRNA followed by linear scanning to the initiation
codon [1]. However many viral and a small number of cellular
RNAs have been shown to initiate translation by ‘Internal
Ribosome Entry Site (IRES)’ mechanism in a 59cap-independent
manner [2]. Internal initiation is thought to facilitate translation of
certain mRNAs under conditions when cap-dependent translation
is less efficient, such as under heat shock, amino- acid starvation
etc [3,4]. Recently we have shown that the 59UTR of the
interferon regulatory factor 2 (IRF2) mRNA contains an IRES
element. Its activity does not seem to be affected under various
stress conditions such as ER stress, coxsackievirus 2A protease
treatment etc. [5].
Interferon regulatory factors are DNA-binding proteins, which
are known to control interferon (IFN) gene expression. IRF1
function as an activator of IFN and IFN-inducible genes, whereas
IRF2 act as repressor of IRF1 action [6]. Interestingly, IRF2 has
also been implicated to stimulate certain genes under various
conditions, such as vascular cell adhesion molecule (VCAM),
histone H4 genes etc [7,8]. The IRES activity of IRF2 gene
ensures basal levels of the IRF2 protein, which might have a role
in cellular response to various conditions of stress. The exact
mechanism of the cellular IRES activity is still not completely
understood. But it is believed that certain IRES trans acting factors
or ITAFs might play an important role in the function [9]. Several
ITAFs, such as La, PTB, unr, hnRNPC have been shown to
influence the activity of various cellular IRES [10–12]. Earlier we
have shown that Polypyrimidine tract binding protein (PTB)
interacts with the 59 UTR of the RNA and was found to be
essential for its activity [5]. PTB has been shown to act as RNA
chaperone and facilitate Apaf1-IRES structure and influence the
efficiency of its translation initiation [13]. It has also been reported
to positively regulate the IRES mediated translation of HIF-1a,
p27kip1 [14,15].
PLoS ONE | www.plosone.org 1 September 2009 | Volume 4 | Issue 9 | e7049We have partially mapped the secondary structure of the IRF2
59UTR using various enzymatic and chemical modification
probes. The data validates the predicted MFOLD structure of
the 59UTR RNA. To map the putative contact points of the
protein on the IRF2 59 UTR we have performed primer extension
inhibition assay. PTB was found to have multiple contact points on
the IRF2 RNA, but mostly at the 39end of the 59UTR. Since many
contact points were found on the 39 end of the RNA, a deletion
mutant was generated, where 25 nt from 39end was deleted. UV
cross-linking and competition experiments showed a reduced
binding of the purified PTB on the mutant RNA as compared to
the wild type RNA. The above data was supported by Circular
Dichroism (CD) spectra analysis of the RNA, which also suggested
a change in the conformation of IRF2 59 UTR in presence of PTB
binding. Proteins from whole cell extracts showed that full length
IRF2 IRES interacted predominantly with a 57 kDa (PTB)
protein, compared to the mutant IRF2. Further PTB silencing
experiments showed reduced PTB binding along with significant
reduction in binding of other cellular trans-acting factors.
Ribosome binding analysis also indicated that supplementation
of purified PTB enhanced the formation of translation initiation
complex. This led us to hypothesize that PTB interaction with the
IRF2 IRES might trigger a change in the conformation that helps
in the recruitment of other hitherto unknown trans acting factors
and ribosomes, thus facilitating translation initiation.
Results
Probing the secondary structure of the IRF2 IRES
DMS modification. Earlier we have shown that the putative
secondary structure of IRF2 59UTR RNA (predicted by using the
MFOLD program) [5,16]. Here we have probed the secondary
structure of IRF2 IRES RNA by monitoring the accessibility of
nucleotides to chemical modification (DMS) and enzymatic
digestions. Dimethylsulphate (DMS) reacts with N-1 position of
adenine residues and to N-3 of cytosine residues in the single
stranded regions [18]. Base pairing inhibits chemical modifications
at these positions. Since chemically modified residues are unable to
base pair with the complementary deoxynucleotides, modification
results in the inhibition of the primer extension by the RT one
nucleotide before the point of modification.
IRF2 monocistronic RNA was generated from the correspond-
ing DNA construct (Fig. 1A). The RNA was treated with DMS
and followed by primer extension using AMV-RT. The products
were then analyzed on 8% polyacrylamide-8M urea denaturing
gel in conjunction with corresponding DNA sequencing ladder to
allow the identification of modified nucleotides. Several RT pauses
were observed, which include A75, A84, C85, U92, A94, C106,
U123, C149, C162, C164 (Fig. 1B). The data suggests that the
IRF2 IRES is highly structured as very few nucleotides were
modified by DMS. The modified nucleotides were mostly found in
the single stranded region of the RNA which validates the
MFOLD prediction.
RNase T1 digestion
Further, RNase T1 digestion was carried out following primer
extension inhibition assay protocol described in material and
methods. in vitro transcribed IRF2 UTR RNA was incubated with
RNase T1 followed by extension using AMV-RT (Promega). The
products were analyzed on 8% polyacrylamide-8M urea denatur-
ing gel. For precise mapping of the contact points, a DNA
sequencing reaction with the same end labeled primer was run
alongside (labeled as C, T, A, G). Since IRF2 59UTR folds into a
fairly stable secondary structure, only few specific RT pauses were
observed at G8, G44, G59, G69, G83 and G131 (Fig. 1C). The
putative pauses were mapped on the predicted secondary structure
(MFOLD) of IRF2 IRES RNA.
RNase VI digestion
In addition, IRF2 IRES RNA was further probed by RNase VI
cleavage. RNase VI is from cobra venom which cleaves double
stranded or other base paired regions [17]. For this purpose, the
IRF2 RNA was incubated with RNase VI and extracted with
phenol:chloroform. The precipitated RNA components were
reverse transcribed using a radiolabeled 39 primer and extended
by AMV-RT. The products were then analyzed on 8%
polyacrylamide-8M urea denaturing gel in conjunction with
corresponding DNA sequencing ladder to allow identification of
modified residues (Fig. 2A). The data supported highly structured
IRF2 UTR as observed in above experiments and showed very
few RNase V1 modified nucleotides. These pauses include (G19,
G46, C121, U137 and G148) (Fig. 2A). These nucleotides are
expected to be in double-stranded region of the RNA and thus
validate the predicted MFOLD structure.
Analysis of PTB binding site by Toe printing
The binding region of PTB on IRF2 UTR was further analyzed
by Toe-printing. The unlabeled RNA was incubated with PTB
and primer extension inhibition assay was carried out as described
earlier. The intensity of few RT pauses was increased in presence
of PTB suggesting possible contact points. The pauses corresponds
to U95, C106, C116, C128, U130, U137, U138, U142, U146,
U151, A161, A163, U165, C175 (Fig. 2B).
The nucleotide modifications (by DMS), the pauses correspond-
ing to nuclease (TI and VI) cleavage sites and the toe prints
corresponding to PTB binding sites were mapped to MFOLD
predicted structure for clarity (Fig. 3). The results suggest that the
IRF2 59UTR contains distinct stem-loop structures and PTB binds
to multiple points within the 59UTR.
39 deletion mutant of IRF2 59 UTR RNA showed reduced
PTB binding
The toe-printing data showed that the contact points of PTB are
predominantly at the 39 end of the IRF2 59UTR RNA. To
investigate this further, 25 nucleotides were deleted at the 39end
from the IRF2 59 UTR to generate mIRF2 (Fig. 4A). To compare
the PTB binding ability of the wt and mutant IRF2 IRES, UV
cross-linking experiment was performed using increasing concen-
trations of the purified PTB protein. As expected, the mutant
RNA showed lesser binding as compared to the wild type RNA
(Fig. 4B). To validate this further, competition UV cross-linking
experiment was performed using unlabeled wt and mIRF2 UTR
RNAs. For this purpose
32P labeled wild type IRF2 59UTR RNA
was incubated with 0.87 nM of purified PTB protein in absence
and presence of increasing concentrations of the competitor
RNAs. Results showed that 100 and 300 fold molar excess of the
cold self IRF2 59UTR RNA successfully competed PTB binding
with the radio labeled 59UTR probe (Fig. 4C), whereas the mutant
IRF2 RNA showed less efficient competition compared to the wild
type (Fig. 4C).
39 deletion mutant of IRF2 59 UTR RNA show reduced
IRES activity
Since 39 deletion mutant showed reduced PTB binding, we
hypothesized that this might also affect the IRF2-IRES activity.
To investigate it, the deletion mutant was cloned in the bicistronic
plasmid construct (Fig. 5A). Both wild type and mutant bicistronic
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cells. The upstream reporter (Renilla luciferase) of the bicistronic
RNA was translated by cap-dependent mode, whereas the
downstream reporter (Firefly luciferase) was translated by the
IRES element. The results showed considerable decrease in firefly
luciferase activity in the mutant (pRDEmIRF2F), suggesting that
loss of PTB binding might have direct consequence with the IRES
activity (Fig. 5B).
Figure 1. Probing of secondary structure of IRF2 UTR RNA with DMS and RNase T1: (A) A schematic representation of IRF2-Luc
monocistronic construct used for generating in vitro transcripts by using T7 RNA polymerase. A 20 nucleotide long -
32P labeled reverse primer was
used for reverse transcription indicated by an arrow at the 59 end of luciferase. (B) IRF2 59 UTR RNA was incubated with (lane 2) or without (lane 1)
dimethyl sulphate (DMS). The unmodified and modified RNAs were reverse transcribed and cDNAs were resolved parallel with a sequencing reaction
performed with the same end labeled primer. Modified nucleotides are indicated on the right of the panel. (C) IRF2 59 UTR RNA was incubated with or
without of 1.0 unit of RNase T1 and the undigested and digested RNAs were reverse transcribed and cDNAs were resolved in parallel with a
sequencing reaction performed with the same end labeled primer. Putative cleavage points are indicated by arrows on the right of the panel.
doi:10.1371/journal.pone.0007049.g001
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To further verify the possible conformational change in the
RNA upon protein binding CD spectroscopic studies were
performed. CD spectra of IRF2 59UTR RNA was analyzed in
absence and presence of purified recombinant PTB protein. CD
spectra were obtained in 240 to 320 nm range at 20uC in 0.5 ml
RNA binding buffer. The results showed distinct change in the
wavelengths at which the peak of ellipticity value is reached for
RNA incubated with PTB (260 nm) compared to RNA alone
(256 nm). Also, at this particular wavelength there was significant
increase in the ellipticity value suggesting a change in the
conformation of the IRF2 59UTR RNA in presence of PTB
(Fig. 6). Interestingly, CD spectra of mutant RNA with PTB
showed less change in the ellipticity value as compared to the wild
type RNA (Fig. 6). As a negative control, BSA was incubated with
the IRF2 RNA, which did not show any change in the ellipticity
value of the RNA. A CD spectrum of PTB alone was performed
and has been depicted in figure 6. Taken together the results
suggest possible role of PTB protein in mediating conformational
alteration in the IRF2 IRES structure to facilitate internal
initiation of translation.
PTB depletion in S10 extract lead to reduced binding of
other trans acting factors
We have also investigated the binding profile of HeLa cell
extracts with IRF2 UTR.
32P labeled Wt and mIRF2 UTR RNAs
Figure 2. RNase VI digestion and Toe-printing of PTB on IRF2 UTR RNA: (A) IRF2 59 UTR RNA was incubated with (lane 2) or without (lane 1)
of 0.01 units of RNase V1. The unmodified and modified RNAs were reverse transcribed and cDNAs were resolved parallel with a sequencing reaction
performed with the same end labeled primer. Cleaved nucleotides are indicated on the right of the panel. (B) For toe-printing, IRF2 wt 59 UTR RNA
was incubated in absence or presence of purified recombinant PTB protein. The RNAs in the Ribonucleoprotein complexes were reverse transcribed
and the cDNAs were resolved in 8M urea 8% PAGE in parallel with a sequencing ladder corresponding to IRF2 59UTR RNA obtained by using the same
end labeled primer. The cDNA products terminated at the sites due to protein binding is indicated on the right.
doi:10.1371/journal.pone.0007049.g002
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PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e7049Figure 3. Schematic diagram MFOLD structure of IRF2 59UTR: Predicted secondary structure of IRF2 59UTR generated by MFOLD indicating
putative contact points of PTB, DMS modification, RNase V1 or T1 cleavage sites.
doi:10.1371/journal.pone.0007049.g003
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and analysed on SDS-PAGE. The results indicated that wtIRF2
59UTR interacted strongly with 57 kDa protein (PTB), whereas
with mIRF2 59UTR the intensity of the band corresponding to
57 kDa protein was relatively less. Interestingly, the mIRF2
showed binding with additional proteins, some of those could be
the cleavage products of PTB (p25), which might negatively
influence IRES activity [21] (Fig. 7A). Finally to investigate
whether PTB facilitates interaction of other trans acting factors to
enhance translation, PTB depleted HeLa S10 was used in UV
cross linking study. PTB was partially silenced in HeLa cells by
using increasing concentration of siPTB. 36 hours post transfection
S10 extracts were prepared. A significant decrease of PTB protein
level was observed at 60 nm & 80 nm concentration of siPTB.
UV-crosslinking experiment was performed using wt IRF2 RNA
probes and S10 extracts from control or siPTB treated cells.
Interactions of several cellular proteins were found to be
significantly reduced (Fig. 7B). These include proteins of range
approximately p120, p110, p57, p45, p29. Additionally, the
extract was subjected for western blot analysis to confirm PTB
Figure 4. UV Crosslinking of PTB with wt IRF2 59UTR and 39 end deletion mutant: (A) A schematic representation of wt and mIRF2 UTRs
used in UV-cross linking and translation studies. (B) Purified PTB was incubated with
32PIRF2 59UTR (lanes 2–4) or with
32P mIRF2 59UTR RNA (lanes 5–
7). The RNA protein complexes were UV cross linked and analyzed on SDS 10% PAGE followed by phosphorimaging. Lane N represents no protein
control. (C) Purified recombinant PTB protein was incubated with
32P IRF2 59UTR in absence (lane 2) or presence of 100 and 200 fold molar excess of
self cold IRF2 59UTR (Lanes 3–4) or mIRF2 RNA (lanes 5–6). The RNA protein complexes were UV cross linked and analyzed on SDS 10% PAGE followed
by phosphorimaging. Lane N represents no protein control. The bands were quantified using densitometric analysis and the values have been
represented below the panel.
doi:10.1371/journal.pone.0007049.g004
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might play a crucial role in bringing some of these proteins to
facilitate ribosome loading and enhance translation initiation.
PTB enhances ribosome assembly at the IRF2 IRES
Further we wanted to study the effect of PTB on IRF2 IRES
mediated translation initiation complex formation. For this
purpose,
32P UTP labeled IRF2 UTR RNA was incubated with
in the in vitro translation mix containing RRL and amino acids.
The reactions were supplemented with purified PTB in two
reactions. The ribosome complexes were resolved on sucrose
density gradients as described in materials and method. GMPPNP
(which terminates ribosome assembly at the 48S stage) and
cycloheximide (which trap 80S ribosomal complexes) were used to
confirm the 48S and 80S ribosomal peaks. The results showed that
the supplementation of PTB marginally enhanced the formation of
48S initiation complex compared to control (Fig. 8). It is possible
that PTB binds to IRF2 UTR and melts the secondary structure to
facilitate the landing of 43S ribosome on to the IRF2 IRES.
Discussion
The mechanism of IRES mediated translation in cellular RNA
is still not completely understood. Various IRES trans acting
factors or ITAFs have been implicated to have role in mediating
internal initiation of translation. Polypyrimidine-tract-binding
protein (PTB) has been implicated as an important ITAF for a
number of viral as well as cellular IRESs. It is believed that PTB
has a chaperone like activity that can bring about a change in the
conformation of the IRES structure, which might facilitate the
interaction of the ribosomes with the RNA leading to efficiently
initiate translation.
In this paper, we have investigated the interaction of PTB with
the IRF2-IRES RNA and studied its importance on its translation
initiation. Multiple contact points were mapped on the IRF2 IRES
RNA. A significant number of those contact points were mapped
to the 39 end of the IRES element. In fact, Apaf-1 IRES is also
known to have two potential PTB binding sites at the 39 end
region [13]. This might be a logistic position for PTB binding to
facilitate binding of the ribosome in the vicinity of the iAUG, the
translation start site. Deletion of 25 nt from the 39end of the IRF2
IRES RNA showed reduced PTB binding. Although, the IRES
function was severely impaired, it was not completely abrogated
perhaps due to residual PTB binding through other sites within the
59UTR, which might still contribute to IRES function. It is also
possible that there is a minor change in the local structure of the
mutant RNA due to deletion that has contributed to the decrease
in the IRES activity.
However recent report suggests that the IRES activity might not
completely depend on the overall structure but on different
sequence modules that play important role in the ITAF
recruitment [19]. This was supported by UV crosslinking for Wt
and mIRF2 RNA probes in presence of purified PTB and HeLa
S10 extracts. As expected mIRF2 showed significantly reduced
binding with PTB when compared to wtIRF2. Also, in HeLa S10
extracts, we found that the wt IRF2 RNA showed a stronger
binding with the 57 kDa protein as compared to the mIRF2.
Interestingly, smaller polypeptides were found to specifically bind
to the mIRF2. At this stage we are not sure about the functional
significance of the binding of these smaller polypeptides to the
mIRF2; however it is tempting to speculate that these proteins
might negatively influence the translation initiation in the mIRF2
RNA.
Nuclease mapping and chemical modifications partly revealed
the secondary structure of the IRF2 59UTR, which largely
supports the MFOLD prediction. DMS modification interference
assay indicated perturbation of the RNA structure in presence of
PTB. The presence of PTB masked the RNA, rendering it
inaccessible to DMS modifications at certain places. Also, a few
new DMS modification sites were found under such condition,
suggesting changes in local structure due to protein binding. CD
spectroscopic analysis reinforces the idea of change in RNA
conformation upon protein binding. In fact when CD experiment
was performed with the mutant IRF2 IRES RNA and the PTB
protein, change in molar ellipticity was found to be less than that
obtained with the wild type RNA. PTB has been shown to have
chaperone like activity, thus it would be interesting to study how its
interaction with the IRF2 59 UTR RNA and consequent change
in the RNA conformation helps in ribosome assembly during
internal initiation. Also it is possible that such a change in the
conformation of the RNA might recruit certain other trans acting
factors near the vicinity of the translation start site that would
facilitate the recruitment of the ribosomes to the RNA and thus
facilitating translation initiation. To further consolidate the
observation, S10 extract isolated from HeLa cells, partially
silenced for PTB expression was used for binding using Wt
IRF2 probe. Several cellular tran-acting factors were unable to
bind Wt IRF2 in reduced presence of PTB. Interestingly, we found
that supplementing the in vitro translation mix with purified PTB
Figure 5. Deletion of 39 end IRF2 UTR RNA showed reduced
activity: (A) Schematic representation of bicistronic construct used for
translation studies. (B) Bicistronic plasmid (1 mg) either pRDEIRF2F or
pRDE39d25IRF2F were transiently transfected into HeLa cells. 16 hrs
post transfection, respective luciferase activities corresponding to Fluc
and RLuc were measured and shown separately. Transfection efficien-
cies were normalized by co-transfecting with a b-galactosidase plasmid.
The data represents mean6s.d. from three independent experiments.
doi:10.1371/journal.pone.0007049.g005
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complex.
Thus we hypothesize that PTB serves as an ITAF which recruits
other possible trans-acting factors that could facilitate IRES mode
of translation initiation in the IRF2 mRNA. However, at this stage
it is not clear how PTB or other IRES trans-acting factors (ITAFs)
interaction helps in switching on the IRES activity of the cellular
IRES elements. It could be a complex interplay of PTB and
several other ITAFs. Future experiments would be directed to
understand how the ITAFs binding directs the ribosome to land
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Plasmid constructs
The bicistronic constructs containing respective 59UTR se-
quences of full length IRF2 (NCBI accession number
NM_002199) and 39 deletion IRF2 (pRDEIRF2F, pRDEmIRF2F)
were cloned downstream of the landscape of structure derived
form the inactive part of DEMCV IRES sequence between Renilla
luciferase (RLuc) and Firefly luciferase (FLuc) genes, in HindIII
and EcoRI sites. The construct pRDEnullF [20] was a kind gift
from Dr. Peter Sarnow (Stanford University). For constructing
IRF2 monocistronic plasmid pIRF2Fluc and mIRF2Luc were
generated from respective bicistronic plasmids by releasing out the
insert IRF2 Fluc by HindIII and ApaI enzymes (NEB) and cloned
in pCDNA 3.1- Fluc.
Cell lines and Transfection
HeLa S3 cells were maintained in DMEM (Invitrogen) with 10%
fetalbovineserum(GIBCO,Invitrogen).Cellsweretransfectedwith
various bicistronic plasmids and pSV40b-gal using Tfx 20 reagent
(Promega) and luciferase assay was performed using Dual luciferase
assay reagent (Promega). Transfection of siRNA was performed in
HeLa S3 cells growing in monolayer using Lipofectamine-2000
transfection reagent and optiMEM-I prepared without addition of
antibiotic (Invitrogen). Cells were seeded onto 100 mm dishes in
duplicates one day prior to transfection in similar manner.
Transfections were performed with 40 nm, 60 nm and 80 nm of
siPTB (Dharmacon) or 80 nm of nonspecific si (Dharmacon) diluted
with optiMEM-I to a final volume of 100 ml followed by incubation
at room temperature for 20 minutes. Subsequently, 4.9 ml of
optiMEM-I was added to the transfection mixture, which was then
layered onto cells. 4 hours later the medium was replaced with 9 ml
of DMEM (with antibiotic) and 10% FBS. 36 hours post
transfection the cells were washed with PBS, and were trypsinized
followed by HeLa S10 extract preparation. S10 extract was
prepared from HeLa cells as described before (22).
In vitro Transcription
The IRF2 59UTR and mIRF2 RNA probes were made from
IRF2Fluc and mIRF2Luc DNA plasmids respectively linearized
with Eco RI and was transcribed by T7 RNA polymerase.
Similarly, the
32P labeled RNA probes corresponding to the
59UTRs of IRF2 and deletion mutant IRF2 were made from their
respective plasmid DNAs after linearizing with EcoRI and
transcribed with T7 RNA polymerase and 10 mCi/ml of alpha
32P UTP (NEN) as per manufacturer’s guidelines.
Purification of recombinant PTB
The expression of recombinant PTB (NCBI accession number
NM_031990) from PET28a-PTB (a generous gift from Dr. J.G.
Patton) was induced by 0.6 mM IPTG in E.coli (BL21 DE3) cells
transformed with the expression vector. His-tagged protein was
purified using Ni
2+-nitrilotriacetic acid-agarose (Qiagen) under
non-denaturing conditions and eluted with 250 mM imidazole.
Figure 6. CD spectroscopic analysis of IRF2 in presence of PTB protein: CD spectra were obtained in 0.5 ml RNA-binding buffer between 240
and 320 nm wavelength range at 20uC with IRF2 59UTR or mIRF2 59UTR in absence or presence of purified PTB or bovine serum albumin (BSA).
doi:10.1371/journal.pone.0007049.g006
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32P labeled IRF2 WT 59UTR and mIRF2 59UTR
were crosslinked with total HeLa S10 extracts and run on an 10% SDS PAGE followed by phosphorimaging. Lane 1 represents no protein control. Lane
M indicates the molecular mass marker. (B) 70% confluent HeLa cells were transfected with 60 nm and 80 nm of siPTB or nsp si as indicated. 36 hrs
post-transfection the cells were harvested and subjected for western blot analysis to check PTB levels. S10 extract was prepared from these cells and
UV Crosslinking was performed as mentioned previously. Lane M indicates the molecular mass marker. (C) Western-blot analysis showing the reduced
levels of PTB with increasing concentration of siPTB. Actin protein was detected as loading control.
doi:10.1371/journal.pone.0007049.g007
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10 mgo fin vitro transcribed IRF2 bicistronic RNAs were
denatured at 65uC for 10 minutes and then cooled slowly to room
temperature. The RNAs were then digested with 0.5 unit of RNase
T1 (SIGMA) for 15 minutes at 37uC. After incubation the reaction
mixture was treated with proteinase K followed by phenol:chloro-
form extraction and alcohol precipitation. For RNase V1 (Ambion)
digestion, the RNA was incubated with 0.01 units of RNase V1 for
10 minutes at 30uC. After the incubation the reaction mixture was
extracted with phenol: chloroform and alcohol precipitated. T1
digestions were carried out in the buffer containing 10 mM Tris.Cl
(pH 7.5), 10 mM MgCl2, and 100 mM KCl. The DMS modifica-
tion was carried out in the buffer containing 50 mM sodium
cacodylate (pH 7.5), 5 mM MgCl2, 100 mM KCl at 30uC for 10
minutes using 1 ml of DMS diluted 1:8 in absolute ethanol. The
modified RNAs were precipitated with ethanol. The digested and
the modified RNAs were reverse transcribed using AMV RT
(Promega) with an end labeled primer annealing to 1–20 at the 59
end of the firefly luciferase gene. The cDNAs were precipitated with
0.3 M sodium acetate and absolute ethanol and then resolved in a
8M urea-8% Acrylamide gel electrophoresis along with a reference
sequencing reaction (fmol kit, Promega) using the same end-labeled
primer. Similarly, purified PTB bound RNA in buffer was modified
with 1 ml of DMS diluted 1:8 in absolute ethanol at 30uC for 10
minutes The modified RNAs were precipitated with ethanol the
modified RNAs were reverse transcribed using AMVRT (Promega)
with an end labeled primer annealing to 1–20 at the 59 end of the
firefly luciferase gene and was analyzed as mentioned before.
Primer extension inhibition analysis or Toe-printing
Increasing concentration of purified his-tagged PTB protein
(500 and 800 ng) was incubated with 5 pmoles of in vitro
transcribed RNA corresponding to the IRF2 bicistronic RNA
(derived from the construct pRIRF2F) and binding reaction was
performed in a final volume of 20 mla t3 0 uC for 20 minutes.
Reaction where PTB was not added serve as a negative control.
To the reactions, [
32P]-end labeled primer complimentary to 20
nucleotides of the 59 end of the Firefly luciferase was added and
allowed to extend using 3 units of AMV-Reverse transcriptase
(Promega) at 30uC for one hour. The cDNAs were alcohol
precipitated, resuspended and compared with the dideoxynucleo-
tide sequence ladders (obtained using same end-labeled primer) by
electrophoresis on a 6% polyacrylamide/8M urea denaturing gel.
CD spectroscopy
Measurements of CD spectra were performed with a Jasco J-
715 spectropolarimeter. Spectra were obtained in 0.5 ml RNA-
binding buffer (5 mM HEPES, pH 7.6, 25 mM KCl, 2 mM
MgCl2, 3.8% glycerol, 2 mM DTT, 0.1 mM EDTA). CD spectra
were obtained in 240 to 320 nm range at 20uC with IRF2 59UTR
(400 ng) and 800 ng of PTB or bovine serum albumin (BSA).
UV-cross linking
RNA binding and UV crosslinking experiment was carried out
following the details described earlier (5). Briefly, [a-
32P] 59UTR
RNAs were allowed to form complex with purified PTB or the
Figure 8. Analysis of translation initiation complex formation in presence of recombinant PTB:
32P UTP labeled IRF2 UTR was incubated
with RRL and amino acid mix and analyzed by sucrose density gradients. Panel A represents the control. Panel B shows the profile of the respective
reactions supplemented with either 1.75 or 3.5 nM of purified recombinant PTB protein (as indicated). The panels C–D shows the effect of addition of
either GMPPNP (panel C) or Cycloheximide (panel D) used to confirm the 48S and 80S ribosomal peaks (indicated by arrows).
doi:10.1371/journal.pone.0007049.g008
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unbound RNAs were digested with RNase A treatment. The
protein RNA complexes were then resolved in a SDS-10%
polyacrylamide gel followed by phosphorimaging analysis.
Western-blot analysis
Protein concentration of the S10 extract prepared from HeLa
cells were assayed by Bradford (Bio-Rad). Equal amounts of cell
extracts were loaded on SDS-10% polyacrylamide gel. The
resolved proteins were electro-transferred to nitrocellulose mem-
branes. Samples were then analysed by mouse monoclonal anti-
PTB antibody (Calbiochem), followed by secondary antibody
(horseradish peroxidase- conjugated anti-mouse; Sigma). Rabbit
polyclonal anti-actin (Sigma) was used as control for equal loading
of total cell extracts. Antibody complexes were detected using the
enhanced chemiluminescence (ECL) detection kit (Amersham
Antibodies).
Ribosome assembly
IRF2 UTR RNA was labeled with
32P UTP and the 25 ml
reactions containing 17.5 ml RRL (Promega), 1.5 ml of amino acid
mix (Promega) and PTB was supplemented as indicated in the
figure legends. Labeled RNA 100,000 cpm was used per reaction.
The reactions were incubated at 30uC for 20 min. and the volume
was made upto 150 ml with the sucrose density gradient buffer
(20 mM Tris HCl, pH 7.5, 100 mM KCl, 2 mM MgCl2 and
1 mM DTT). The reactions were overlaid on 5–30% linear
sucrose density gradients and centrifuged for 3 hrs at 30,000 rpm
using SW41 rotor in Beckman ultracentrifuge. 200 ml fractions
were collected from top of the radioactive tube. Counts of each
fraction were measured and %cpm was plotted against the fraction
number.
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